Pyxis Oncology, Inc.
NASDAQ:PYXS
4.42 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -73.79 | -120.717 | -75.975 | -12.828 | -2.772 |
| Depreciation & Amortization
| 2 | 0.709 | 0.647 | 0.469 | 0 |
| Deferred Income Tax
| 3.507 | 0 | 6.281 | 0 | 0 |
| Stock Based Compensation
| 16.946 | 15.764 | 6.441 | 0.044 | 0.028 |
| Change In Working Capital
| -11.664 | 4.501 | 6.676 | 2.287 | 0.505 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -3.507 | -8.328 | 4.643 | 0.558 | 0.292 |
| Other Working Capital
| -8.157 | 12.829 | 2.033 | 1.729 | 0.213 |
| Other Non Cash Items
| -7.708 | 10.408 | 20.604 | -0.056 | -0.264 |
| Operating Cash Flow
| -70.709 | -89.335 | -35.326 | -10.084 | -2.239 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -6.726 | -6.399 | -0.54 | -1.483 | 0 |
| Acquisitions Net
| 6.66 | 0 | -0.05 | 0 | 0 |
| Purchases Of Investments
| -196.831 | 0 | -0.05 | 0 | 0 |
| Sales Maturities Of Investments
| 92.048 | 0 | 0.05 | 0 | 0 |
| Other Investing Activites
| -0.105 | 0 | -0 | 0 | 0 |
| Investing Cash Flow
| -104.849 | -6.399 | -0.59 | -1.483 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 6.374 | 0.183 | 152.296 | 0.035 | 0.013 |
| Common Stock Repurchased
| -0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.445 | 0 | 151.748 | 0 | 21.942 |
| Financing Cash Flow
| 5.929 | 0.183 | 304.044 | 0.035 | 21.955 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -169.629 | -95.551 | 268.128 | -11.532 | 19.716 |
| Cash At End Of Period
| 11.136 | 180.765 | 276.316 | 8.188 | 19.72 |